Incepta Pharmaceuticals Ltd. Sustainability Profile
Incepta Pharmaceuticals Ltd., a leading player in the pharmaceutical industry, is headquartered in Dhaka, Bangladesh. Founded in 2003, the company has rapidly established itself as a key provider of high-quality generic medicines, active pharmaceutical ingredients (APIs), and innovative formulations across various therapeutic areas. With a strong presence in both domestic and international markets, Incepta is committed to enhancing healthcare through its diverse portfolio, which includes products in oncology, cardiology, and anti-infectives. The company is recognised for its state-of-the-art manufacturing facilities and adherence to stringent quality standards, positioning it as a trusted name in the industry. Incepta's dedication to research and development, alongside its strategic partnerships, has led to significant milestones, including the introduction of several first-to-market products. This commitment to excellence has solidified its reputation as a pioneer in the pharmaceutical landscape of Bangladesh and beyond.
DitchCarbon Score
How does Incepta Pharmaceuticals Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Incepta Pharmaceuticals Ltd.'s score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Incepta Pharmaceuticals Ltd.'s reported carbon emissions
Incepta Pharmaceuticals Ltd., headquartered in Bangladesh (BD), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Incepta Pharmaceuticals may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). As the pharmaceutical industry increasingly prioritises sustainability, it is essential for companies like Incepta to consider implementing measurable climate commitments and reduction strategies to align with global efforts in combating climate change. Without specific emissions data or reduction initiatives, Incepta Pharmaceuticals may face challenges in demonstrating its environmental responsibility and commitment to sustainability in the competitive pharmaceutical landscape.
How Carbon Intensive is Incepta Pharmaceuticals Ltd.'s Industry?
How Carbon Intensive is Incepta Pharmaceuticals Ltd.'s Location?
Incepta Pharmaceuticals Ltd.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Incepta Pharmaceuticals Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.